Suchergebnisse - "d'Ettorre, Gabriella"

PubPharm (8)

1

Real-Life Impact of Drug Toxicity on Dolutegravir Tolerability : Clinical Practice Data from a Multicenter Italian Cohort

enthalten in: Viruses | 2022

von Ciccullo, A. | Baldin, G. | Borghi, V. | +13

2

Five Years With Dolutegravir Plus Lamivudine as a Switch Strategy : Much More Than a Positive Finding

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2021

von Ciccullo, A. | Borghi, V. | Giacomelli, A. | +13

3

Real word outcomes associated with use of raltegravir in older people living with HIV : results from the 60 months follow-up of the RAL-age cohort

enthalten in: Expert review of anti-infective therapy | 2020

von Santinelli, L. | Ceccarelli, G. | Borrazzo, C. | +10

4

Long-term data on the efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multi-centre cohort of HIV-1-infected, virologically suppressed patients

enthalten in: International journal of antimicrobial agents | 2019

von Baldin, G. | Ciccullo, A. | Rusconi, S. | +11

5

A prospective randomized trial on abacavir/lamivudine plus darunavir/ritonavir or raltegravir in HIV-positive drug-naïve patients with CD4<200 cells/uL (the PRADAR study)

enthalten in: PloS one | 2019

von Mussini, C. | Roncaglia, E. | Borghi, V. | +15

6

Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification : a multicenter observational study

enthalten in: BMC infectious diseases | 2016

von Latini, A. | Fabbiani, M. | Borghi, V. | +11

7

Effects of raltegravir on 2-long terminal repeat circle junctions in HIV type 1 viremic and aviremic patients

enthalten in: AIDS research and human retroviruses | 2013

von Bona, R. | Baroncelli, S. | D'Ettorre, G. | +10

8

Maraviroc as intensification strategy in HIV-1 positive patients with deficient immunological response : an Italian randomized clinical trial

enthalten in: PloS one | 2013

von Rusconi, S. | Vitiello, P. | Adorni, F. | +26

1
[1]